Cargando…
Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro
BACKGROUND: Doxorubicin is a widely used anticancer drug due to its broad spectrum of antitumor activity. Various mechanisms have been proposed for its cytostatic activity, including DNA intercalation, topoisomerase II inhibition, generation of free radicals and apoptosis. The present study aims to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180587/ https://www.ncbi.nlm.nih.gov/pubmed/30338246 http://dx.doi.org/10.1186/s40709-018-0089-z |
_version_ | 1783362234749026304 |
---|---|
author | Chondrou, Vasiliki Trochoutsou, Katerina Panayides, Andreas Efthimiou, Maria Stephanou, Georgia Demopoulos, Nikos A. |
author_facet | Chondrou, Vasiliki Trochoutsou, Katerina Panayides, Andreas Efthimiou, Maria Stephanou, Georgia Demopoulos, Nikos A. |
author_sort | Chondrou, Vasiliki |
collection | PubMed |
description | BACKGROUND: Doxorubicin is a widely used anticancer drug due to its broad spectrum of antitumor activity. Various mechanisms have been proposed for its cytostatic activity, including DNA intercalation, topoisomerase II inhibition, generation of free radicals and apoptosis. The present study aims to further clarify the cytostatic activity of doxorubicin by its specific effect on (a) DNA damage, (b) micronucleation and (c) apoptosis, using a combination of different methods and cell systems such as human lymphocytes and HL-60 human leukemic cells. DNA lesions were analyzed by the alkaline comet assay in combination with formamidopyrimidine (Fpg) and human 8-oxoguanine (hOGG1) repair enzymes. Micronucleation was investigated by the Cytokinesis-Block Micronucleus assay (CBMN) in combination with Fluorescence In Situ Hybridization analysis. Impairment on mitotic apparatus was investigated by double immunofluorescence of β- and γ-tubulin. Apoptotic cell frequency was determined by the CBMN cytome assay. Complementary to the above, caspase-3 level was investigated by Western blot. RESULTS: It was found that doxorubicin generates DNA breakage induced by oxidative damage in DNA bases, which can be repaired by the Fpg and hOGG1 enzymes. Increased micronucleus frequency was identified mainly through chromosome breakage and, at a lesser extent, through chromosome delay. Analysis of mitotic spindle showed disturbance of chromosome orientation and centrosome duplication and/or separation, leading to aneuploidy. Enhanced frequency of apoptotic leukemic cells was also observed. Caspase-3 seems to be involved in the generation of apoptosis. CONCLUSIONS: The aforementioned findings derived from different treatment schedules, doses and time of exposure on primary versus transformed cells extend our knowledge about doxorubicin genotoxicity and contribute to the better understanding of the mechanisms by which doxorubicin induces genotoxic effects on human cells. |
format | Online Article Text |
id | pubmed-6180587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61805872018-10-18 Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro Chondrou, Vasiliki Trochoutsou, Katerina Panayides, Andreas Efthimiou, Maria Stephanou, Georgia Demopoulos, Nikos A. J Biol Res (Thessalon) Research BACKGROUND: Doxorubicin is a widely used anticancer drug due to its broad spectrum of antitumor activity. Various mechanisms have been proposed for its cytostatic activity, including DNA intercalation, topoisomerase II inhibition, generation of free radicals and apoptosis. The present study aims to further clarify the cytostatic activity of doxorubicin by its specific effect on (a) DNA damage, (b) micronucleation and (c) apoptosis, using a combination of different methods and cell systems such as human lymphocytes and HL-60 human leukemic cells. DNA lesions were analyzed by the alkaline comet assay in combination with formamidopyrimidine (Fpg) and human 8-oxoguanine (hOGG1) repair enzymes. Micronucleation was investigated by the Cytokinesis-Block Micronucleus assay (CBMN) in combination with Fluorescence In Situ Hybridization analysis. Impairment on mitotic apparatus was investigated by double immunofluorescence of β- and γ-tubulin. Apoptotic cell frequency was determined by the CBMN cytome assay. Complementary to the above, caspase-3 level was investigated by Western blot. RESULTS: It was found that doxorubicin generates DNA breakage induced by oxidative damage in DNA bases, which can be repaired by the Fpg and hOGG1 enzymes. Increased micronucleus frequency was identified mainly through chromosome breakage and, at a lesser extent, through chromosome delay. Analysis of mitotic spindle showed disturbance of chromosome orientation and centrosome duplication and/or separation, leading to aneuploidy. Enhanced frequency of apoptotic leukemic cells was also observed. Caspase-3 seems to be involved in the generation of apoptosis. CONCLUSIONS: The aforementioned findings derived from different treatment schedules, doses and time of exposure on primary versus transformed cells extend our knowledge about doxorubicin genotoxicity and contribute to the better understanding of the mechanisms by which doxorubicin induces genotoxic effects on human cells. BioMed Central 2018-10-11 /pmc/articles/PMC6180587/ /pubmed/30338246 http://dx.doi.org/10.1186/s40709-018-0089-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chondrou, Vasiliki Trochoutsou, Katerina Panayides, Andreas Efthimiou, Maria Stephanou, Georgia Demopoulos, Nikos A. Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro |
title | Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro |
title_full | Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro |
title_fullStr | Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro |
title_full_unstemmed | Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro |
title_short | Combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro |
title_sort | combined study on clastogenic, aneugenic and apoptotic properties of doxorubicin in human cells in vitro |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180587/ https://www.ncbi.nlm.nih.gov/pubmed/30338246 http://dx.doi.org/10.1186/s40709-018-0089-z |
work_keys_str_mv | AT chondrouvasiliki combinedstudyonclastogenicaneugenicandapoptoticpropertiesofdoxorubicininhumancellsinvitro AT trochoutsoukaterina combinedstudyonclastogenicaneugenicandapoptoticpropertiesofdoxorubicininhumancellsinvitro AT panayidesandreas combinedstudyonclastogenicaneugenicandapoptoticpropertiesofdoxorubicininhumancellsinvitro AT efthimioumaria combinedstudyonclastogenicaneugenicandapoptoticpropertiesofdoxorubicininhumancellsinvitro AT stephanougeorgia combinedstudyonclastogenicaneugenicandapoptoticpropertiesofdoxorubicininhumancellsinvitro AT demopoulosnikosa combinedstudyonclastogenicaneugenicandapoptoticpropertiesofdoxorubicininhumancellsinvitro |